fda restrictions on compounding bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank 83% of peptide-aware Americans want
83% of peptide aware Americans want the FDA to make peptides more accessible AOL Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand Health Law Alliance
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


